Effects of music therapy on autonomic nervous system activity, incidence of heart failure events, and plasma cytokine and catecholamine levels in elderly patients with cerebrovascular disease and dementia

International Heart Journal

Volumn 50, Issue 1, 2009, Pages 95-110

  Okada, Kaoru ^a   Kurita, Akira ^b   Takase, Bonpei ^c   Otsuka, Toshiaki ^d   Kodani, Eitaro ^a   Kusama, Yoshiki ^a   Atarashi, Hirotsugo ^a   Mizuno, Kyoichi ^d  

^a NIPPON MEDICAL SCHOOL TAMA NAGAYAMA HOSPITAL   (Japan)

^b Fukuinkai Medical Clinic   (Japan)

^c NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^d NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Cardiac autonomic activity; Catecholamine; Cytokines; Heart failure; Heart rate variability; Music therapy

Indexed keywords

ADRENALIN; CATECHOLAMINE; CYTOKINE; INTERLEUKIN 6; NORADRENALIN;

ADRENALIN BLOOD LEVEL; AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; CEREBROVASCULAR DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMENTIA; DISEASE ASSOCIATION; ELDERLY CARE; FEMALE; HEART RATE VARIABILITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MUSIC THERAPY; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT DURATION;

AGED, 80 AND OVER; AUTONOMIC NERVOUS SYSTEM; CATECHOLAMINES; CEREBROVASCULAR DISORDERS; CYTOKINES; DEMENTIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART RATE; HUMANS; INCIDENCE; MALE; MUSIC THERAPY; TREATMENT OUTCOME;

EID: 61749090649     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.50.95     Document Type: Article

References (50)

1. Kokumin Eisei no Doukou. Vol. 52. In: Jinkou doutai. Tokyo: Health and Welfare Statistics Association; 2006: 33-7. (Japanese)
2. Yoshitake T, Kiyohara Y, Kato I, et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology 1995: 45: 1161-8.
3. Matsumoto M. Cerebrovascular disease in the elderly people. Nippon Ronen Igakkai Zasshi 2006; 43: 152-4. (Japanese)
4. Bradley L, Siddique CM, Dufton B. Reducing the use of physical restraints in long-term care facilities. J Gerontol Nurs 1995; 21: 21-34.
5. Hall GR, Buckwalter KC. Progressively lowered stress threshold: a conceptual model for care of adults with Alzheimer's disease. Arch Psychiatr Nurs 1987; 1: 399-406.
6. Thomas DR. Assessment and management of agitation in the elderly. Geriatrics 1988; 43: 45-50, 53.
7. Meyer LB. Emotion and meaning in music. Chicago: University of Chicago, IL; 1956: 1-23.
8. Munro S, Mount B. Music therapy in palliative care. Can Med Assoc J 1978; 119: 1029-34.
9. Guzzetta CE. Music therapy: Healing the melody of the soul. In: Holistic Nursing. A Handbook for Practice. Dossey BM, Keegan L, Guzzetta CE (Eds). Gaitherburg, Aspen, MD; 1995: 679-98.
10. Lai HL. Music preference and relaxation in Taiwanese elderly people. Geriatr Nurs 2004; 25: 286-91.
11. Vollert JO, Störk T, Rose M, Möckel, M. Music as adjuvant therapy for coronary heart disease. Therapeutic music lowers anxiety, stress and beta-endorphin concentrations in patients from a coronary sport group. Dtsch Med Wochenschr 2003; 128: 2712-6. (German)
12. Chlan L, Tracy MF. Music therapy in critical care: Indications and guidelines for intervention. Crit Care Nurse 1990; 19: 35-41. (Review)
13. Barnason S, Zimmerman L, Nieveen J. The effects of music interventions on anxiety in the patient after coronary artery bypass grafting. Heart Lung 1995; 24: 124-32.
14. White JM. Music therapy: an intervention to reduce anxiety in the myocardial infarction patient. Clin Nurse Spec 1992; 6: 58-63.
15. Carney RM, Freedland KE, Jaffe AS, et al. Depression as a risk factor for post-MI mortality. J Am Coll Cardiol 2004; 44: 472.
16. Dickens C, McGowan L, Percival C, et al. Depression is a risk factor for mortality after myocardial infarction: Factor artifact? J Am Coll Cardiol 2007; 49: 1834-40.
17. Maggio M, Gruralnik JM, Longo DL, Ferrucci L. Interleukin-6 in aging and chronic disease: A magnificent pathway. J Gerontol A Biol Sci Med Sci 2006: 61: 575-84. (Review)
18. Ershler WB. Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc 1993; 41: 176-81. (Review)
19. Wei J, Xu H, Davies JL, Hemmings GP. Increase of plasma IL-6 concentration with age in healthy subjects. Life Sci 1992; 51: 1953-56.
20. Meldrum DR. Tumor necrosis factor in the heart. Am J Physiol 1998; 274: R577-95. (Review)
21. Ferrucci L, Harris TB, Guralnik JM, et al. Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc 1999; 47: 639-46.
22. Declaration of Helsinki (1964). BMJ 1996; 313: 1448-9.
23. Kobayashi T, Hataguchi K, Nishimura K, et al. Simple dementia scale. Rinsho Seishingaku 1988; 17: 1653-68. (Japanese)
24. Hunt SA, Abraham WT, Chin MH, et al; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005; 112: e154-235.
25. Ohtomo N, Sumi A, Tanaka Y, Tokiwano K, Terachi S. A detailed study of power spectral density for Rossler system. J Phy Soc Jpn 1996; 65: 2811-23.
26. Heart Rate Variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996; 93: 1043-65.
27. Singer DH, Martin GJ, Magid N, et al. Low heart rate variability and sudden cardiac death. J Electrocardiol 1988; 21: S46-55. (Review)
28. Anderson KP, Bigger JT Jr, Freedman RA. Electrocardiographic predictors in the ESVEM trial: unsustained ventricular tachycardia, heart period variability, and the signal-averaged electrocardiogram. Prog Cardiovasc Dis 1996; 38: 463-88. (Review)
29. Malik M. Heart rate variability. Curr Opin Cardiol 1998; 13: 36-44. (Review)
30. Kurita A, Hamabe A, Takase B, Hikita H, Nagayoshi H. Usefulness of a single time-domain heart rate variability index for assessment of cardiac events. Analysis of circadian cardiac autonomic tone, cardiac risk factors, and QT intervals. J Natl Def Med Coll 1999; 24: 125-36).
31. Guzzetti S, Borroni E, Garbelli PE, et al. Symbolic dynamics of heart rate variability: a probe to investigate cardiac autonomic modulation. Circulation 2005; 112: 465-70.
32. Kurita A, Matsui T, Ishizuka T, Takase B, Satomura K. Modulation of electrical microvolt level T-wave alternans and left ventricular late potentials evaluated by heart rate variability indices, QT dispersion, and plasma catecholamine levels. A.N.E. 2000; 5: 262-9.
33. Kurita A, Takase B, Okada K, et al. Effects of music therapy on heart rate variability in elderly patients with cerebral vascular disease and dementia. J Arrhythmia 2006; 22: 161-6.
34. Ikonomidis I, Athanassopoulos G, Lekakis J, et al. Myocardial ischemia induces interleukin-6 and tissue factor production in patients with coronary artery disease: a dobutamine stress echocardiography study. Circulation 2005; 112: 3272-9.
35. Murray DR. Freeman GL. Proinflammatory cytokines: predictors of a failing heart? Circulation 2003: 107: 1460-2.
36. Tracey KJ. The inflammatory reflex. Nature 2002: 420: 853-9. (Review)
37. Vasan RS, Sullivan LM, Roubenoff R, et al: Framingham Heart Study. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: The Framingham Heart Study. Circulation 2003; 107: 1486-91.
38. Blalock JE. The immune system as a sensory organ. J Immunol 1984; 132: 1067-70. (Review)
39. Blalock JE. Shared ligands and receptors as a molecular mechanism for communication between the immune and neuroendocrine systems. Ann N Y Acad Sci 1994; 741: 292-8. (Review)
40. Malliani A, Pagani M. The role of the sympathetic nervous system in congestive heart failure. Eur Heart J 1983; 4: 49-54.
41. Davila DF, Donis JH, Ballabarbe, G, Torres A, Casado J, Mazzei de Davila C. Cardiac afferents and neurohormonal activation in congestive heart failure. Med Hypotheses 2000; 54: 242-53.
42. Zucker IH. Left ventricular receptors: physiological controllers or pathological curiosities? Basic Res Cardiol 1986; 81: 539-57. (Review)
43. Ludbrook J. Cardiovascular reflexes from cardiac sensory receptors. Aust N Z J Med 1990; 20: 597-606. (Review)
44. Hainsworth R. Reflexes from the heart. Physiol Rev 1991; 71: 617-58. (Review)
45. Thorén P. Role of cardiac vagal C-fibers in cardiovascular control. Rev Physiol Brochem Pharmacol 1979; 86: 1-94. (Review)
46. Gilmore JP. Neural control of extracellular volume in the human and nonhuman primate: In: Handbook of Physiology. Vol III. The Cardiovascular System. Shepherd JT, Abboud AM (Eds) Waverly Press, Bethesda, MD; 1983: 885-9.
47. DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev 1997; 77: 75-197. (Review)
48. Porter TR, Eckberg DL, Fritsch JM, et al. Autonomic pathophysiology in heart failure patients. Sympathetic-cholinergic interrelations. J Clin Invest 1990; 85: 1362-71.
49. Davila DF, Donis JH, Bellabarba G, Torres A, Casado J, Mazzei de Davila C. Cardiac afferents and neurohormonal activation in congestive heart failure. Med Hypotheses 2000; 54: 242-53.
50. Kaye D, Esler M. Sympathetic neuronal regulation of the heart in aging and heart failure. Cardiovasc Res 2005; 66: 256-64. (Review)